News Sentiment

RFL sentiment intelligence

Rafael Holdings, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 54 relevant articles
Exchange NYSE United States
Sector Real Estate Market context
Industry Real Estate Services Read-through group
Latest close 2.73 Week of 19 Jun 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+21.9% over one week, +103.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Rafael Holdings Inc (RFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction 21.9% Price confirming higher
Trend fit Trend active 103.7% over four weeks
Fair value 64.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 34
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 8
TradingKey 7
The Manila Times 3
Quiver Quantitative 3
GlobeNewswire 2
Investing.com Canada 2
The Globe and Mail 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 21
Deals and strategy 6
Balance sheet 2
Guidance 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
The Manila Times Direct company coverage

Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results

Rafael Holdings, Inc. announced its financial results for the third quarter and first nine months of fiscal year 2026. The company reported a net loss of $4.2 million for the third quarter and $20.5 million for the nine months, largely due to the acquisition of Cyclo Therapeutics

Tone
Positive 70/100
Event
Deals and strategy
Published
12 Jun 2026 09:10
Source
The Manila Times
Stock Titan Direct company coverage

[8-K] Rafael Holdings, Inc. Reports Material Event

Rafael Holdings, Inc. has reported its third-quarter fiscal 2026 results, highlighting a significant clinical milestone: the completion of the last patient last visit in its pivotal Phase 3 TransportNPC™ trial for Niemann-Pick Disease Type C1. The company anticipates submitting a

Tone
Positive 66/100
Event
Earnings
Published
11 Jun 2026 11:41
Source
Stock Titan
Stock Titan Direct company coverage

Rare disease trial milestone: Rafael plans 2026 NPC drug filing

Rafael Holdings (NYSE: RFL) reported its Q3 fiscal 2026 financial results, including a net loss of $4.2 million and $30.5 million in cash. The company announced the completion of the pivotal Phase 3 TransportNPC trial and expects to submit a New Drug Application (NDA) in the seco

Tone
Positive 60/100
Event
Earnings
Published
11 Jun 2026 11:41
Source
Stock Titan
Investing.com Canada Direct company coverage

Rafael Holdings completes phase 3 NPC disease trial enrollment By Investing.com

Rafael Holdings (NYSE:RFL) has announced the completion of enrollment for its Phase 3 TransportNPC trial, evaluating Trapsol Cyclo for Niemann-Pick Disease Type C. This milestone led to a positive market response, with shares surging 43% over the past week. The company expects to

Tone
Positive 70/100
Event
Guidance
Published
10 Jun 2026 11:39
Source
Investing.com Canada
Investing.com Direct company coverage

Rafael Holdings completes phase 3 NPC disease trial enrollment

Rafael Holdings (NYSE:RFL) has announced the completion of enrollment for its Phase 3 TransportNPC trial for Niemann-Pick Disease Type C, with the last patient finishing their 96-week visit. The company's stock surged on this news, and topline results are expected in the second h

Tone
Positive 82/100
Event
Earnings
Published
10 Jun 2026 07:37
Source
Investing.com
Longevity.Technology Direct company coverage

Rafael Holdings gains exclusive MIT Alzheimer’s patent

Rafael Holdings, through its subsidiary Cyclo Therapeutics, has secured an exclusive licensing agreement with MIT for a patent targeting ApoE4-linked Alzheimer's disease. The deal focuses on using small molecules, specifically cyclodextrins like Trappsol Cyclo, to improve brain c

Tone
Positive 72/100
Event
Deals and strategy
Published
29 Apr 2026 02:38
Source
Longevity.Technology
Quantisnow Direct company coverage

Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors

Rafael Holdings, Inc. (NYSE: RFL) has announced the appointment of three biopharmaceutical leaders to its Board of Directors: Ameet Mallik, CEO of Rafael Holdings; Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc.; and Mark McCamish, M.D., Ph.D., President and CEO of Ic

Tone
Positive 72/100
Event
Market update
Published
21 Apr 2026 11:09
Source
Quantisnow